Development of Homologous Recombination Functional Assays for Targeting the DDR
{{output}}
Identification of tumours that have homologous recombination deficiency (HRD) has become of increasing interest following the licensing of PARP inhibitors. Potential methods to assess HRD status include; clinical selection for platinum sensitive disease, mutat... ...
